» Authors » Asger Sverrild

Asger Sverrild

Explore the profile of Asger Sverrild including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 397
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stojanovic S, Sverrild A, Tay T, Denton E, Murthee K, Lin T, et al.
Ann Allergy Asthma Immunol . 2025 Feb; PMID: 39929392
Background: Inducible laryngeal obstruction (ILO) is confirmed by observing paradoxical vocal fold movement (PVFM) on laryngoscopy, but test sensitivity is reduced by its intermittent nature. Specificity of isolated expiratory PVFM...
2.
von Bulow A, Hansen S, Sandin P, Cooper A, Ernstsson O, Geale K, et al.
J Allergy Clin Immunol Pract . 2025 Feb; PMID: 39900241
Background: The link between the use of oral corticosteroids (OCS) and adverse events (AEs) in asthma is well described. In contrast, whether the use of high-dose inhaled corticosteroids (ICS) poses...
3.
Norheim K, Ben Ezra M, Heckenbach I, Andreasson L, Eriksen L, Dyhre-Petersen N, et al.
Nat Aging . 2024 Nov; 4(12):1772-1781. PMID: 39548320
Chronic obstructive pulmonary disease (COPD) is a progressive, incurable disease associated with smoking and advanced age, ranking as the third leading cause of death worldwide. DNA damage and loss of...
4.
Wong M, Gardner L, Denton E, Borg B, Dharmakumara M, Mahoney J, et al.
J Sci Med Sport . 2024 Oct; 28(2):95-100. PMID: 39419690
Objectives: Abnormal breathlessness at maximal exercise may be caused by a range of conditions, including exercise-induced bronchospasm, breathing pattern disorder, or exercise-induced laryngeal obstruction. These three disorders may not be...
5.
Ghanizada M, Jabarkhil A, Hansen S, Woehlk C, Dyhre-Petersen N, Sverrild A, et al.
J Asthma . 2024 Aug; 61(12):1715-1726. PMID: 39169832
Objective: Acute exacerbations (AEs) of asthma are heterogeneous in terms of triggers, outcomes, and treatment response. This study investigated biomarker defined infective and inflammatory AE phenotypes in hospitalized adult asthma...
6.
Strong A, Lin T, Sverrild A, Mackay A, Lee J, Zubrinich C, et al.
ERJ Open Res . 2024 Jul; 10(4). PMID: 39040583
https://bit.ly/3JgZ5Ya.
7.
Sondergaard M, Madsen F, Sverrild A, Porsbjerg C
Ugeskr Laeger . 2024 Apr; 186(14). PMID: 38606702
In the last 30 years, the treatment of obstructive lung diseases, such as asthma and COPD, has seen significant advancements. Introduction of inhaled corticosteroids (ICS) and, more recently, biological treatments...
8.
Russell R, Boulet L, Brightling C, Pavord I, Porsbjerg C, Dorscheid D, et al.
Eur Respir J . 2024 Mar; 63(4). PMID: 38453256
Asthma is a disease of heterogeneous pathology, typically characterised by excessive inflammatory and bronchoconstrictor responses to the environment. The clinical expression of the disease is a consequence of the interaction...
9.
Andreasson L, Dyhre-Petersen N, Hvidtfeldt M, Jorgensen G, von Bulow A, Klein D, et al.
J Allergy Clin Immunol . 2023 Dec; 153(4):988-997.e11. PMID: 38081546
Background: Thymic stromal lymphopoietin (TSLP) is released from the airway epithelium in response to various environmental triggers, inducing a type-2 inflammatory response, and is associated with airway inflammation, airway hyperresponsiveness...
10.
von Bulow A, Hansen S, Sandin P, Ernstsson O, Janson C, Lehtimaki L, et al.
Eur Respir J . 2023 Aug; 62(3). PMID: 37620041
Background: There is limited evidence on the pathways leading to severe asthma and we are presently unable to effectively predict the progression of the disease. We aimed to describe the...